The University of Chicago Header Logo

Connection

Veeral Sheth to Humans

Back to Details
This is a "connection" page, showing publications Veeral Sheth has written about Humans.
Veeral Sheth
Connection Strength
0.234
Humans
  1. Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections. Ophthalmol Retina. 2025 Apr; 9(4):330-342.
    View in: PubMed
    Score: 0.029
  2. Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis. BMJ Open Ophthalmol. 2022; 7(1):e000957.
    View in: PubMed
    Score: 0.024
  3. Private Equity's Game Plan and Why it Should Matter to Us. Ophthalmic Surg Lasers Imaging Retina. 2020 08 01; 51(8):424-427.
    View in: PubMed
    Score: 0.021
  4. PERIPHERAL RETINOPATHY ASSOCIATED WITH APLASTIC ANEMIA. Retin Cases Brief Rep. 2017 Spring; 11(2):108-110.
    View in: PubMed
    Score: 0.017
  5. An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. Ophthalmic Surg Lasers Imaging Retina. 2017 02 01; 48(2):100-104.
    View in: PubMed
    Score: 0.017
  6. Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol. 2012 Mar; 130(3):396-8.
    View in: PubMed
    Score: 0.012
  7. Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophy. Arch Ophthalmol. 2008 May; 126(5):745-6; author reply 746.
    View in: PubMed
    Score: 0.009
  8. Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. JAMA Ophthalmol. 2025 04 01; 143(4):326-335.
    View in: PubMed
    Score: 0.007
  9. Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Am J Ophthalmol. 2025 Jul; 275:14-26.
    View in: PubMed
    Score: 0.007
  10. Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study. Eye (Lond). 2025 Apr; 39(6):1099-1106.
    View in: PubMed
    Score: 0.007
  11. Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices. JAMA Ophthalmol. 2024 Aug 01; 142(8):716-721.
    View in: PubMed
    Score: 0.007
  12. Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration. Sci Rep. 2024 06 26; 14(1):14752.
    View in: PubMed
    Score: 0.007
  13. Screen Failures in Clinical Trials in Retina. Ophthalmol Retina. 2024 Nov; 8(11):1093-1099.
    View in: PubMed
    Score: 0.007
  14. Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials. Ophthalmol Retina. 2024 Nov; 8(11):1052-1060.
    View in: PubMed
    Score: 0.007
  15. Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial. JAMA Ophthalmol. 2023 12 01; 141(12):1152-1160.
    View in: PubMed
    Score: 0.007
  16. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21; 402(10411):1449-1458.
    View in: PubMed
    Score: 0.007
  17. The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results. Eye (Lond). 2023 12; 37(17):3574-3581.
    View in: PubMed
    Score: 0.006
  18. A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2022 07; 239:180-189.
    View in: PubMed
    Score: 0.006
  19. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study. Ophthalmology. 2022 06; 129(6):605-613.
    View in: PubMed
    Score: 0.006
  20. Reply. Ophthalmol Retina. 2021 01; 5(1):e1-e2.
    View in: PubMed
    Score: 0.005
  21. Macular Hole Closure with Medical Treatment. Ophthalmol Retina. 2021 07; 5(7):711-713.
    View in: PubMed
    Score: 0.005
  22. Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization. Ophthalmol Retina. 2021 04; 5(4):348-356.
    View in: PubMed
    Score: 0.005
  23. ACTINOMYCES NEUII ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION. Retin Cases Brief Rep. 2017 Summer; 11(3):281-282.
    View in: PubMed
    Score: 0.004
  24. Cystoid macular edema associated with fingolimod use for multiple sclerosis. JAMA Ophthalmol. 2013 Jan; 131(1):103-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.